Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

NUR370 Pathophysiology and Pharmacology > Medications for Cardiovascular Diseases > Flashcards

Medications for Cardiovascular Diseases Flashcards

(49 cards)

Start Studying
1
Q

Goals of Dyslipidemia Therapy

A

a. increase HDL
b. lower LDL and TG

reduce CAD

TARGET LDL levels <2.0 mmol/L
or
>50% decrease in LDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HMG-CoA Reductase Inhibitor (Statins)

A

= inhibit rate limiting enzyme in cholesterol synthesis
- most effective agents to #lowering LDL, also #^HDL and #lowers TG

Onset: 2 weeks, max efficacy in 4-6 weeks
Dose: once daily at bedtime, PO only

Prototype: ATORVASTATIN (Lipitor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Statins Side Effects

A

a. hepatotoxicity (~1%)
contraindicated in liver disease, monitor LFTs
site of metabolism is liver, usually occurs early on

b. myopathy (0.5%)
muscle ache or weakness, monitor creatine kinase (CK)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Statins Drug Interactions

A

some statins metabolized by CYP450

  • CYP450 inhibitors may increase risk of statin accumulation and myopathy
  • avoid grapefruit juice

fibrates, niacin
- increases risk of myopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Fibric Acid Derivative (Fibrates)

A

= increases breakdown of TG and facilitate HDL formation, enhances cholesterol elimination in bile
- most effective agent in #lowering TG, also #^HDL, small effect on LDL

Onset: 3-4 weeks
Dose: once daily with meal for absorption, PO only

Prototype: FENOFIBRATE (LipidilMicro)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Fibrates Side Effects

A

a. gallstones
- due to increased cholesterol saturation of bile

b. GI effects
- nausea, dyspepsia, diarrhea

c. myopathy
d. rash
e. hepatotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Fibrates Drug Interactions

A

statin
- increased risk of myopathy

warfarin
- increased risk in bleeding, monitor INR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bile Acid Sequestrants (Resins)

A

= resins bind bile acids in gut to increase excretion
= increase bile acid production in liver to remove cholesterol from blood, cholesterol is building block for bile acid
- modest #lowering of LDL, #small ^HDL and TG
- mainly used in combination with statin

Onset: 1 week, max effect in 4 weeks
Dose: take 30-60 mins prior to meal
- mix powder or granules with fluid, cannot take in dry form due choking hazard

Prototype: CHOLESTYRAMINE (Questran)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Resins Side Effects

A 
GI upsets (nausea, constipation, bloating, abdo pain, flatulence)
- not absorbed in blood stream, eliminated in feces
  • only agent safe in pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Resins Drug Interactions

A

can reduce absorption of other drugs:

a. fat soluble vitamins (ADEK)
b. some anionic drugs (digoxin, warfain, levothyroxine, thiazides, fibrates)

GENERAL RULE: administer all other meds 1 hour before or 4 hours after resin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Key Concepts of Dyslipidemia Therapy

A
  • statins are most effective
  • onset of action is weeks
  • lifestyle intervention enhances therapeutic effects
  • contraindications:
    a. only resins safe in pregnancy
    b. avoid statin and caution with fibrates with liver disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Determinant of Oxygen Supply and Demand

A

Supply
- myocardial blood flow via coronary vessels

Demand

  1. heart rate
  2. myocardial contractility
  3. cardiac preload
  4. cardiac afterload
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Key Principle of Pharmacotherapy for CAD

A

a. CAD leads to imbalance between myocardial oxygen supple and demand
b. drug therapy for angina is aimed at reducing oxygen demand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Determinants of Blood Pressure

A

Arterial pressure = Cardiac Output x Peripheral Resistance

Cardiac Output:
- heart rate, contractility, preload, afterload

Peripheral Resistance:
- arteriolar constriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Beta-blockers

A

Indications: prevent anginal attack, acute MI, HF, HTN, dysrhythmias
Dose: PO once or twice daily, some IV forms available

“-olol”

a. Non-selective agents =PROPRANOLOL=
block both b1 and b2 receptors

b. Cardioselective agents =METOPROLOL=
block b1 only

c. vasodilating beta-blockers =CARVEDILOL=
block alpha1-adrenergic receptors and beta receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

b-blockers: mechanism of action

A

a. block b1 receptors
b. decrease renin release by blocking b1 receptors in kidney
c. decrease peripheral vascular resistance
d. blunt reflex tachycardia from HTG and other vasodilators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

b-blockers: side effects

A

a. bradycardia
assess HR before administration

b. reduce cardiac output

c. bronchoconstriction
b2 receptor blockade

d. hypoglycemia
b2 receptor blockade prevent glycogenolysis in liver, suppress glucose production

e. CNS effects (sleep disturbances, fatigue, depression)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

b-blockers: drug interactions

A

combined with CCB may cause excessive cardiosuppression

do not stop abruptly
- rebound cardiac excitation can cause tachycardia, dysrhythmia, angina or MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Alpha1-adrenergic Blockers

A

Indications: #hypertension and benign prostatic hyperplasia (BPH)
Dose: once daily, preferably at bedtime
- start low go slow

“-osin”

=TERAZOSIN=

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

a1-adrenergic blockers: mechanism of action

Study These Flashcards
A

block a1 receptors on arterioles and veins, preventing vasoconstriction

21
Q

a1-adrenergic blockers: side effects

Study These Flashcards
A

a. orthostatic hypotension
can be severe especially with first dose
dizziness, lightheadedness, fainting
dose at night

b. increased reflex HR to compensate
c. nasal congestion

d. sexual dysfunction
inhibition of ejaculation

22
Q

Angiotensin Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers

Study These Flashcards
A

Indications: HTN, HF, acute MI, prevent CV events in high risk patients
Dose: once or twice daily, PO (only exception enalaprilat IV)
- start low, go slow

ACE inhibitor =RAMIPRIL=
“-pril”

ARBs =LOSARTAN=
“-sartan”

  • ARB if pt develops cough on ACE inhibitor
  • rare to see pt on both ACE and ARB, risk of renal dysfunction
23
Q

ACE Inhibitors: mechanism of action

Study These Flashcards
A

a. inhibit angiotensin II production
- decreased angiotensin II leads to vasodilation, which leads to increased cardiac output
- reduce aldosterone release and promotes excretion
- prevent cardiac and vascular remodelling by decreasing sympathetic transmission, thereby reducing O2 demand

b. blockade of bradykinin breakdown

24
Q

ARBs: mechanism of action

Study These Flashcards
A

a. blockade of angiotensin II receptors
- prevent vasoconstriction
- prevent aldosterone release
- decrease blood volume
- prevent cardiac remodelling, reduce O2 demand

*do not prevent breakdown of bradykinin

25
ACE inhibitors and ARBs: side effects
a. first dose hypotension start low, go slow b. decrease glomerular filtration pressure small increase in serum creatinine, small decrease in GFR (rarely clinically significant) c. hyperkalemia reduced K+ excretion, avoid potassium supplements d. fetal harm contraindicated in pregnancy SPECIFIC TO ACE INHIBITORS ONLY e. inhibition of ACE increases bradykinin, histamine-like compound - dry, irritating, non-productive cough(~10%) (subsides when d/c ACE inhibitors) - angioedema (1%), swelling of lower layer of skin and muscous membrane
26
ACE inhibitors and ARBs: drug interactions
a. diuretics intensifies first dose hypotension b. other anti-hypertensives avoid additive effects c. drugs that increase K+ d. NSAIDs: Na+ retention, vasoconstriction reduces effect of ACE inhibitors, counterproductive
27
Aldosterone Receptor Blockers
Indications: HTN and HF Dose: once daily, PO Onset: 48 hrs a. non-selective =SPIRONOLACTONE= aldosterone antagonist b. selective =EPLERENONE=
28
aldosterone receptor blockers: mechanism of action
aldosterone stimulates synthesis of Na+/K+ exchange pumps in distal tube aldosterone blockade causes Na+ excretion, which lowers blood volume and pressure
29
aldosterone receptor blockers: side effects
a. hyperkalemia b. endocrine effect (spironolactone only) binds to steroid hormone receptors causing gynecomastia, menstrual irregularities, impotence and hirsutism
30
aldosterone receptor blockers: drug interactions
a. caution with other drugs that increase K+ ACE inhibitors, ARBs, K+ supplements, K+ sparing diuretics b. some CYP450 inhibitors can increase eplereone
31
Diuretics
Indications: HTN, HF (often first line therapy) Dose: once or twice daily, AM and afternoon, PO - IV furosemide a. Thiazide =HYDROCLOROTHIAZIDE= site of action: distal convoluted tubule, sodium delivery to distal tube causes K+ loss *renal impairment affects Na+ travelling to distal tubule Onset: 2 hr b. Loop =FUROSEMIDE= site of action: thick ascending loop of Henle, K+ loss at proximal tubule *more powerful diuretic, causes vasodilation, second-line Onset: 1 hr PO, 5 min IV c. Potassium-sparing =TRIAMTERENE, AMILORIDE= - non-aldosterone antagonists, aldosterone antagonists site of action: late distal tubule and collecting duct *usually an add-on, used to counteract potassium loss Onset: 2-3 hrs used alone or combined with other agents generally inexpensive
32
diuretics: mechanism of action
a. block reabsorption of Na+ and Cl- in renal tubules, salt and water excretion b. increase urine flow c. decrease blood volume thereby decreasing bp
33
diuretics: side effects
a. nocturia avoid dosing at night, dose AM b. decreased K+ using thiazide and loop combine with K+ sparing agent or K+ supplement c. dehydration loop diuretics cause decrease Na+, decreased Mg2 ototocity in high IV doses d. hyperkalemia, leg crames, dizziness, blue urine K+ sparing agents such as triamterene
34
diuretics: drug interactions
a. NSAIDs causes salt and water retention (counterproductive) b. loop and thiazide increase risk of digoxin toxicity c. K+ sparing agents avoid ACE inhibitors, ARBs, potassium supplements (risk of hyperkalemia)
35
Calcium channel blockers (CCBs)
Indications: angina, HTN, arrhythmias a. agents that affect blood vessels, dihydropyridines =AMLODIPINE= Dose: once or twice daily b. agents that affect heart and blood vessels, non-dyhrdopyridines =DILTIAZEM, VERAPAMIL= Dose: long-acting formulations, once daily
36
CCBs: mechanism of action
a. calcium channels regulate contraction of arterioles - blockade causes arteriolar dilation, decreases afterload - biggest effect with dihydropyridines b. calcium channels in myocytes regular contractility and conduction, heart rate - blockade causes decreased contractility and HR, suppress conduction through AV node - biggest effect with non-dihydropyridines
37
CCBs: side effects
a. reflex increase in HR, edema, flushing, headache - due to arteriolar dilation - especially with dihydropyridines, combine with b-blocker to minimize effect on HR b. bradycardia - non-dihydropyridines c. constipation with verapamil blockade of calcium channels in gut smooth muscle
38
CCBs: drug interaction
a. increased cardiosuppression b-blockers with non-dihydropyridines b. both diltiazem and verapamil increases digoxin levels cardiosuppression effect counteract digoxin's inotropic action c. grapefruit juice will increase levels of non-dihydropyridines
39
Digoxin
Indications: HF, dysrhythmias Dose: long half life (~1.5 days), once daily, PO or IV - may use loading dose to reach therapeutic range quickly for dysrhythmia positive inotrope - increase contractility, increase cardiac output negative chronotrope - decrease heart rate NARROW THERAPEUTIC INDEX, needs TDM
40
Digoxin: mechanism of action
``` blocks Na+/K+ exchange pump on myocytes >> increase Ca2+ levels in myocytes >> increase contractility and cardiac output ```
41
digoxin: side effects
may signal toxicity a. GI, anorexia b. fatigue, visual disturbances c. arrhythmias due to electrolyte disturbances, namely decreased K+ - caution use with diuretics or vomiting/diarrhea *K+ and digoxin bind to the same site, therefore, decreased K+ means more digoxin get bound
42
digoxin: drug interactions
a. diuretics (loop and thiazides) risk of toxicity due to K+ loss b. ACE inhibitors, ARBs, K+ sparing diuretic counteracts therapeutic response because it binds to same sites c. verapamil (CCB) increase in digoxin counteracts inotropic actions d. sympathomimetics (i.e. dopamine) further increase contractility and heart rate
43
Nitrates
Indications: angina Dose: SL or transdermal =NITROGLYCERIN= nitroglycerin is highly lipid soluble, half-life is 5-7 mins if given orally, rapidly inactivated by liver (first pass effect) *mainly effects veins instead of arteries
44
nitrates: mechanism of action
nitrate taken up by VSM, gets converted to nitric oxide (NO) in the presence of sulfhydryl groups NO acts on VSM causing #vasodilation
45
nitrates: side effects
a. headache decreases with time, managed with acetaminophen b. orthostatic hypotension due to relaxation of VSM, blood pools in veins c. reflex tachycardia prevent with b-blocker or CCB
46
nitrates: drug interactions
a. b-blockers, some CCBs suppress NTG-induced tachycardia b. increase effects of other anti-hypertensives c. viagra or similar agents intensify NTG-induced vasodilation - do not take within 24 hours of any nitrate d. alcohol vasodilatory effects, may decrease blood pressure
47
nitrate administration
= dosage forms aimed to prevent hepatic metabolism and to prolong therapeutic effects 1. rapid acting to treat angina 2. long acting to prevent angina a. Sublingual - direct absorption, no FP effect - to treat angina: rapid onset (1-3 min), last 1 hr - for chest pains: 1 tab q5min prn x 3 doses - SL tabs or spray, chemically unstable, storage condition important b. Transdermal patch - slow release, absorbed directly, no FP effect - used to prevent angina only - onset: 30-60min, effect lasts as long as patch on - apply new patch daily to hairless area, rotate site * intermittent schedule to prevent tolerance and maintain efficacy, nitrate-free 10-12 hr
48
Multi-drug therapy for hypertension
- use of drugs with different mechanisms to improve success - use lower doses of individual agents to reduce frequency and intensity of side effects - one agent may offset adverse effects of another - non-adherence is the major cause of treatment failure - HTN is often asymptomatic - therapeutic response is not apparent but side effects are
49
Drugs that cause HTN
- oral contraceptives - sympathomimetics - corticosteriods - immunosuppressants - some antidepressants (MAOIs) - thyroid hormone excess - illicit drugs - NSAIDs - caffeine, alcohol, licorice

NUR370 Pathophysiology and Pharmacology (20 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions